BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 18636350)

  • 1. [Clinical value of screening hereditary nonpolyposis colorectal cancer in China with protocol recommended by NCCN guidelines].
    Shen K; Wang S; Ye YJ; Yin MJ; Yang XD; Xu F; Liang B; Jiang KW; Cui ZR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):317-21. PubMed ID: 18636350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
    Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H
    Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of the Amsterdam criteria in a regional German cohort of patients with colorectal cancer.
    Raedle J; Schaffner M; Esser N; Sahm S; Trojan J; Kriener S; Brieger A; Nier H; Bockhorn H; Berg PL; Frick B; Schäfer D; Zeuzem S
    Z Gastroenterol; 2002 Aug; 40(8):561-8. PubMed ID: 12297979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.
    Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D
    Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperplastic polyps in hereditary nonpolyposis colorectal cancer.
    Rijcken FE; van der Sluis T; Hollema H; Kleibeuker JH
    Am J Gastroenterol; 2003 Oct; 98(10):2306-11. PubMed ID: 14572584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
    Lipton LR; Johnson V; Cummings C; Fisher S; Risby P; Eftekhar Sadat AT; Cranston T; Izatt L; Sasieni P; Hodgson SV; Thomas HJ; Tomlinson IP
    J Clin Oncol; 2004 Dec; 22(24):4934-43. PubMed ID: 15611508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germ line mutations of hMSH2 and hMLH1 genes in Japanese families with hereditary nonpolyposis colorectal cancer (HNPCC): usefulness of DNA analysis for screening and diagnosis of HNPCC patients.
    Miyaki M; Konishi M; Muraoka M; Kikuchi-Yanoshita R; Tanaka K; Iwama T; Mori T; Koike M; Ushio K; Chiba M
    J Mol Med (Berl); 1995 Oct; 73(10):515-20. PubMed ID: 8581513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer.
    Luce MC; Marra G; Chauhan DP; Laghi L; Carethers JM; Cherian SP; Hawn M; Binnie CG; Kam-Morgan LN; Cayouette MC
    Gastroenterology; 1995 Oct; 109(4):1368-74. PubMed ID: 7557107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry to detect hereditary nonpolyposis colorectal cancer in young patients: the 7-year Auckland experience.
    Wright DM; Arnold JL; Parry B; Hulme-Moir M; Winship IM; Parry S
    Dis Colon Rectum; 2011 May; 54(5):552-8. PubMed ID: 21471755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hereditary nonpolyposis colorectal cancer].
    Yuasa Y
    Nihon Rinsho; 2000 Jul; 58(7):1396-9. PubMed ID: 10921311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and molecular genetic analysis of 4 typical Chinese HNPCC families.
    Cai Q; Sun MH; Lu HF; Zhang TM; Mo SJ; Xu Y; Cai SJ; Zhu XZ; Shi DR
    World J Gastroenterol; 2001 Dec; 7(6):805-10. PubMed ID: 11854906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic counseling for hereditary cancer.
    Lynch HT; Lynch J
    Oncology (Williston Park); 1996 Jan; 10(1):27-34. PubMed ID: 8924364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observational Study: Familial Relevance and Oncological Significance of Revised Bethesda Guidelines in Colorectal Patients That Have Undergone Curative Resection.
    Jung WB; Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
    Medicine (Baltimore); 2016 Feb; 95(6):e2723. PubMed ID: 26871811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptance of and attitude toward genetic testing for hereditary nonpolyposis colorectal cancer: a comparison of participants and nonparticipants in genetic counseling.
    Keller M; Jost R; Kadmon M; Wüllenweber HP; Haunstetter CM; Willeke F; Jung C; Gebert J; Sutter C; Herfarth C; Büchler MW
    Dis Colon Rectum; 2004 Feb; 47(2):153-62. PubMed ID: 15043284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of hereditary nonpolyposis colorectal cancer syndrome in a selected area of the Lombardy Cancer Registry.
    Cornaggia M; Tibiletti MG; Albarello L; Taborelli M; Dalla Longa E; Capella C
    Tumori; 2000; 86(6):439-44. PubMed ID: 11218182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC.
    Di Fiore F; Charbonnier F; Martin C; Frerot S; Olschwang S; Wang Q; Boisson C; Buisine MP; Nilbert M; Lindblom A; Frebourg T
    J Med Genet; 2004 Jan; 41(1):18-20. PubMed ID: 14729822
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognosis of hereditary nonpolyposis colorectal cancer (HNPCC) and the role of Japanese criteria for HNPCC.
    Fujita S; Moriya Y; Sugihara K; Akasu T; Ushio K
    Jpn J Clin Oncol; 1996 Oct; 26(5):351-5. PubMed ID: 8895676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced colon cancer before the age of 20 years: a case for extension of the current colonoscopy surveillance guidelines in hereditary nonpolyposis colorectal cancer syndrome.
    Wong VK; Yoshida EM; Ryan AG; Ho SG; Salh B
    Can J Gastroenterol; 2004 May; 18(5):319-20. PubMed ID: 15152282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer.
    Ramsey SD; Burke W; Clarke L
    Genet Med; 2003; 5(5):353-63. PubMed ID: 14501830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of gene tests to detect hereditary predisposition to cancer: economic considerations.
    Brown ML; Kessler LG
    J Natl Cancer Inst; 1995 Aug; 87(15):1131-6. PubMed ID: 7674317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.